{"title":"假尿嘧啶5′-磷酸在两步酶促生产中的N-到c -糖苷重排","authors":"Martin Pfeiffer, Franziska Guld, Bernd Nidetzky","doi":"10.1002/bit.29037","DOIUrl":null,"url":null,"abstract":"<p>Pseudouridine (<b>Ψ</b>) is an essential building block of synthetic RNA for medical applications, so methods for its efficient production receive increased interest. Reverse reaction of the <b>Ψ</b>-5′-phosphate (<b>ΨMP</b>) <i>C</i>-glycosidase, that is, <span>d</span>-ribose 5-phosphate (<b>Rib5P</b>) + uracil (Ura) → <b>ΨMP</b> + H<sub>2</sub>O, allows for the installment of the core β-<i>C</i>-riboside structure of <b>Ψ</b> in a completely selective and efficiently equilibrium-driven single-step transformation. However, providing the <b>Rib5P</b> substrate is challenging for process development and optimum solutions can vary depending on the specific production tasks considered. Here, we exploited the less known activity of purine/pyrimidine nucleotide 5′-phosphate nucleosidase (PpnN; EC 3.2.2.10) to cleave uridine 5′-phosphate (<b>UMP</b>), a relatively expedient starting material for <b>ΨMP</b> synthesis, under release of <b>Rib5P</b> and <b>Ura</b>. Using linear cascade transformation in two enzymatic steps performed in one pot, we demonstrate rearrangement of <b>UMP</b> into <b>ΨMP</b> (yield: ≥ 95%) and thereby obtain the <i>C</i>-riboside product at the solubility limit (∼1.5 mol/L) in a productivity of 2.9 × 10<sup>2 </sup>g/L/h. We show that a previously reported R341A-Y347A double variant of <i>Escherichia coli</i> PpnN (RY) exhibited ∼5-fold higher specific activity toward UMP, and was ∼12-fold less sensitive to <b>Rib5P</b> inhibition, than the wild-type enzyme. Under conditions of <i>C</i>-glycosidase applied in twofold excess over PpnN to minimize the effect of <b>Rib5P</b> inhibition, cascade reaction with RY compared to wild-type PpnN still gave ∼5-fold enhanced productivity. In summary, we present a new synthetic route to <b>ΨMP</b> via <i>N</i>- to <i>C</i>-glycoside rearrangement of <b>UMP</b>. Compared to earlier approaches of cascade biocatalysis for <b>ΨMP</b> production from uridine or <b>UMP</b>, this new route is streamlined due to the direct release of <b>Rib5P</b> from the <b>UMP</b> substrate catalyzed by PpnN.</p>","PeriodicalId":9168,"journal":{"name":"Biotechnology and Bioengineering","volume":"122 9","pages":"2456-2464"},"PeriodicalIF":3.6000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bit.29037","citationCount":"0","resultStr":"{\"title\":\"N- to C-Glycoside Rearrangement of Uridine 5′-Phosphate in Two Enzymatic Steps for the Production of Pseudouridine 5′-Phosphate\",\"authors\":\"Martin Pfeiffer, Franziska Guld, Bernd Nidetzky\",\"doi\":\"10.1002/bit.29037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Pseudouridine (<b>Ψ</b>) is an essential building block of synthetic RNA for medical applications, so methods for its efficient production receive increased interest. Reverse reaction of the <b>Ψ</b>-5′-phosphate (<b>ΨMP</b>) <i>C</i>-glycosidase, that is, <span>d</span>-ribose 5-phosphate (<b>Rib5P</b>) + uracil (Ura) → <b>ΨMP</b> + H<sub>2</sub>O, allows for the installment of the core β-<i>C</i>-riboside structure of <b>Ψ</b> in a completely selective and efficiently equilibrium-driven single-step transformation. However, providing the <b>Rib5P</b> substrate is challenging for process development and optimum solutions can vary depending on the specific production tasks considered. Here, we exploited the less known activity of purine/pyrimidine nucleotide 5′-phosphate nucleosidase (PpnN; EC 3.2.2.10) to cleave uridine 5′-phosphate (<b>UMP</b>), a relatively expedient starting material for <b>ΨMP</b> synthesis, under release of <b>Rib5P</b> and <b>Ura</b>. Using linear cascade transformation in two enzymatic steps performed in one pot, we demonstrate rearrangement of <b>UMP</b> into <b>ΨMP</b> (yield: ≥ 95%) and thereby obtain the <i>C</i>-riboside product at the solubility limit (∼1.5 mol/L) in a productivity of 2.9 × 10<sup>2 </sup>g/L/h. We show that a previously reported R341A-Y347A double variant of <i>Escherichia coli</i> PpnN (RY) exhibited ∼5-fold higher specific activity toward UMP, and was ∼12-fold less sensitive to <b>Rib5P</b> inhibition, than the wild-type enzyme. Under conditions of <i>C</i>-glycosidase applied in twofold excess over PpnN to minimize the effect of <b>Rib5P</b> inhibition, cascade reaction with RY compared to wild-type PpnN still gave ∼5-fold enhanced productivity. In summary, we present a new synthetic route to <b>ΨMP</b> via <i>N</i>- to <i>C</i>-glycoside rearrangement of <b>UMP</b>. Compared to earlier approaches of cascade biocatalysis for <b>ΨMP</b> production from uridine or <b>UMP</b>, this new route is streamlined due to the direct release of <b>Rib5P</b> from the <b>UMP</b> substrate catalyzed by PpnN.</p>\",\"PeriodicalId\":9168,\"journal\":{\"name\":\"Biotechnology and Bioengineering\",\"volume\":\"122 9\",\"pages\":\"2456-2464\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bit.29037\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology and Bioengineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.29037\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology and Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.29037","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
假尿嘧啶(Ψ)是用于医学应用的合成RNA的重要组成部分,因此有效生产假尿嘧啶的方法受到越来越多的关注。Ψ-5'-磷酸(ΨMP) c -糖苷酶的逆反应,即d-核糖5-磷酸(Rib5P) +尿嘧啶(Ura)→ΨMP + H2O,允许在完全选择性和有效的平衡驱动的单步转化中安装Ψ的核心β- c -糖苷结构。然而,提供Rib5P衬底对于工艺开发具有挑战性,最佳解决方案可能因所考虑的具体生产任务而异。在这里,我们利用了鲜为人知的嘌呤/嘧啶核苷酸5'-磷酸核苷酶(PpnN;(EC 3.2.2.10)在Rib5P和Ura的释放下裂解尿苷5′-磷酸(UMP),这是合成ΨMP的一种相对方便的起始材料。利用在一个锅中进行的两个酶解步骤的线性级联转化,我们证明了UMP重排为ΨMP(产率:≥95%),从而在溶解度极限(~ 1.5 mol/L)下以2.9 × 102 g/L/h的产率获得c -核苷产物。我们发现,先前报道的大肠杆菌PpnN (RY)的R341A-Y347A双变体对UMP的特异性活性比野生型酶高约5倍,对Rib5P抑制的敏感性低约12倍。在c -糖苷酶用量为PpnN的两倍以减少Rib5P抑制作用的条件下,与RY级联反应相比,与野生型PpnN相比,其产量仍提高了约5倍。综上所述,我们提出了一条通过UMP的N-到c -糖苷重排合成ΨMP的新途径。与早期尿苷或UMP生产ΨMP的级联生物催化方法相比,由于PpnN催化UMP底物直接释放Rib5P,该新途径简化了。
N- to C-Glycoside Rearrangement of Uridine 5′-Phosphate in Two Enzymatic Steps for the Production of Pseudouridine 5′-Phosphate
Pseudouridine (Ψ) is an essential building block of synthetic RNA for medical applications, so methods for its efficient production receive increased interest. Reverse reaction of the Ψ-5′-phosphate (ΨMP) C-glycosidase, that is, d-ribose 5-phosphate (Rib5P) + uracil (Ura) → ΨMP + H2O, allows for the installment of the core β-C-riboside structure of Ψ in a completely selective and efficiently equilibrium-driven single-step transformation. However, providing the Rib5P substrate is challenging for process development and optimum solutions can vary depending on the specific production tasks considered. Here, we exploited the less known activity of purine/pyrimidine nucleotide 5′-phosphate nucleosidase (PpnN; EC 3.2.2.10) to cleave uridine 5′-phosphate (UMP), a relatively expedient starting material for ΨMP synthesis, under release of Rib5P and Ura. Using linear cascade transformation in two enzymatic steps performed in one pot, we demonstrate rearrangement of UMP into ΨMP (yield: ≥ 95%) and thereby obtain the C-riboside product at the solubility limit (∼1.5 mol/L) in a productivity of 2.9 × 102 g/L/h. We show that a previously reported R341A-Y347A double variant of Escherichia coli PpnN (RY) exhibited ∼5-fold higher specific activity toward UMP, and was ∼12-fold less sensitive to Rib5P inhibition, than the wild-type enzyme. Under conditions of C-glycosidase applied in twofold excess over PpnN to minimize the effect of Rib5P inhibition, cascade reaction with RY compared to wild-type PpnN still gave ∼5-fold enhanced productivity. In summary, we present a new synthetic route to ΨMP via N- to C-glycoside rearrangement of UMP. Compared to earlier approaches of cascade biocatalysis for ΨMP production from uridine or UMP, this new route is streamlined due to the direct release of Rib5P from the UMP substrate catalyzed by PpnN.
期刊介绍:
Biotechnology & Bioengineering publishes Perspectives, Articles, Reviews, Mini-Reviews, and Communications to the Editor that embrace all aspects of biotechnology. These include:
-Enzyme systems and their applications, including enzyme reactors, purification, and applied aspects of protein engineering
-Animal-cell biotechnology, including media development
-Applied aspects of cellular physiology, metabolism, and energetics
-Biocatalysis and applied enzymology, including enzyme reactors, protein engineering, and nanobiotechnology
-Biothermodynamics
-Biofuels, including biomass and renewable resource engineering
-Biomaterials, including delivery systems and materials for tissue engineering
-Bioprocess engineering, including kinetics and modeling of biological systems, transport phenomena in bioreactors, bioreactor design, monitoring, and control
-Biosensors and instrumentation
-Computational and systems biology, including bioinformatics and genomic/proteomic studies
-Environmental biotechnology, including biofilms, algal systems, and bioremediation
-Metabolic and cellular engineering
-Plant-cell biotechnology
-Spectroscopic and other analytical techniques for biotechnological applications
-Synthetic biology
-Tissue engineering, stem-cell bioengineering, regenerative medicine, gene therapy and delivery systems
The editors will consider papers for publication based on novelty, their immediate or future impact on biotechnological processes, and their contribution to the advancement of biochemical engineering science. Submission of papers dealing with routine aspects of bioprocessing, description of established equipment, and routine applications of established methodologies (e.g., control strategies, modeling, experimental methods) is discouraged. Theoretical papers will be judged based on the novelty of the approach and their potential impact, or on their novel capability to predict and elucidate experimental observations.